Dow Up 0.07% Nasdaq Up 0.61%

Momenta Pharmaceuticals Inc. (MNTA)

-NasdaqGS
11.78 Up 0.17(1.46%) Nov 26, 4:00PM EST
Prev Close:11.61
Open:11.60
Bid:10.31 x 100
Ask:N/A
1y Target Est:15.50
Beta:1.3
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:11.55 - 11.89
52wk Range:9.38 - 19.90
Volume:284,875
Avg Vol (3m):464,635
Market Cap:607.73M
P/E (ttm):N/A
EPS (ttm):-2.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MNTAUp 1.46%607.73M
GSKUp 0.52%111.83B
SNYUp 0.92%126.20B
TEVAUp 0.41%48.56B

Key Statistics

Forward P/E (1 yr):10.42
P/S (ttm):13.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.70
Quarterly EPS Est (Dec-14) :-0.16
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Momenta Pharmaceuticals, Inc., a biotechnology company, is engaged in the structural characterization, process engineering, and biologic systems analysis of complex molecules in the areas of complex generics, biosimilars, and novel drugs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback